135 related articles for article (PubMed ID: 14510178)
61. IBC's 4th Annual Conference on Molecular Diagnostics. September 13-14, 2005, Convention and Expo Center, Boston, MA, USA.
Jain KK
Expert Rev Mol Diagn; 2005 Nov; 5(6):847-9. PubMed ID: 16255626
[No Abstract] [Full Text] [Related]
62. Predictive and prognostic factors.
Dowsett M
Breast Cancer Res; 2010 Dec; 12 Suppl 4(Suppl 4):S2. PubMed ID: 21172082
[No Abstract] [Full Text] [Related]
63. Breast cancer biomarkers and molecular medicine: part II.
Ross JS; Linette GP; Stec J; Clark E; Ayers M; Leschly N; Symmans WF; Hortobagyi GN; Pusztai L
Expert Rev Mol Diagn; 2004 Mar; 4(2):169-88. PubMed ID: 14995904
[TBL] [Abstract][Full Text] [Related]
64. Breast cancer screening and biomarkers.
Brooks M
Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
[TBL] [Abstract][Full Text] [Related]
65. Biomarkers in Cancer Detection, Diagnosis, and Prognosis.
Das S; Dey MK; Devireddy R; Gartia MR
Sensors (Basel); 2023 Dec; 24(1):. PubMed ID: 38202898
[TBL] [Abstract][Full Text] [Related]
66. Development of Electrochemical Immunosensors for HER-1 and HER-2 Analysis in Serum for Breast Cancer Patients.
Wignarajah S; Chianella I; Tothill IE
Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979567
[TBL] [Abstract][Full Text] [Related]
67. Identification of Key Genes and Key Pathways in Breast Cancer Based on Machine Learning.
Bao S; He G
Med Sci Monit; 2022 May; 28():e935515. PubMed ID: 35607268
[TBL] [Abstract][Full Text] [Related]
68. Tetraspanin 1 (TSPAN1) promotes growth and transferation of breast cancer cells via mediating PI3K/Akt pathway.
Wu Y; Chen W; Gong Y; Liu H; Zhang B
Bioengineered; 2021 Dec; 12(2):10761-10770. PubMed ID: 34852709
[TBL] [Abstract][Full Text] [Related]
69. MarkerDB: an online database of molecular biomarkers.
Wishart DS; Bartok B; Oler E; Liang KYH; Budinski Z; Berjanskii M; Guo A; Cao X; Wilson M
Nucleic Acids Res; 2021 Jan; 49(D1):D1259-D1267. PubMed ID: 33245771
[TBL] [Abstract][Full Text] [Related]
70. Histological Aspects and Quantitative Assessment of Ki67 as Prognostic Factors in Breast Cancer Patients: Result from a Single-Center, Cross Sectional Study.
Niță I; Nițipir C; Toma ȘA; Limbău AM; Pîrvu E; Bădărău IA; Suciu I; Suciu G; Manolescu LSC
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33182401
[No Abstract] [Full Text] [Related]
71. Antitumoral Effect of Laurinterol on 3D Culture of Breast Cancer Explants.
García-Davis S; Viveros-Valdez E; Díaz-Marrero AR; Fernández JJ; Valencia-Mercado D; Esquivel-Hernández O; Carranza-Rosales P; Carranza-Torres IE; Guzmán-Delgado NE
Mar Drugs; 2019 Mar; 17(4):. PubMed ID: 30934912
[TBL] [Abstract][Full Text] [Related]
72. Serum atrial natriuretic peptide: a suspected biomarker of breast cancer.
Houssen ME; Ghazy HF; Farag K; El-Hussiny MAB; El Ghaffar MA; Alsayed SAM; Farouk O
Contemp Oncol (Pozn); 2017; 21(1):54-59. PubMed ID: 28435399
[TBL] [Abstract][Full Text] [Related]
73. Identification of potential serum biomarkers for breast cancer using a functional proteomics technology.
Wang DL; Xiao C; Fu G; Wang X; Li L
Biomark Res; 2017; 5():11. PubMed ID: 28293426
[TBL] [Abstract][Full Text] [Related]
74. Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer.
Balanis N; Carlin CR
Mol Cell Endocrinol; 2017 Aug; 451():24-30. PubMed ID: 28088463
[TBL] [Abstract][Full Text] [Related]
75. Individualized Survival and Treatment Response Predictions in Breast Cancer Patients: Involvements of Phospho-EGFR and Phospho-Her2/neu Proteins.
Guo L; Abraham J; Flynn DC; Castranova V; Shi X; Qian Y
Open Clin Cancer J; 2008 May; 2():18-31. PubMed ID: 25558292
[TBL] [Abstract][Full Text] [Related]
76. A novel model for Ki67 assessment in breast cancer.
Romero Q; Bendahl PO; Fernö M; Grabau D; Borgquist S
Diagn Pathol; 2014 Jun; 9():118. PubMed ID: 24934660
[TBL] [Abstract][Full Text] [Related]
77. Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.
Fry EA; Taneja P; Maglic D; Zhu S; Sui G; Inoue K
PLoS One; 2013; 8(10):e77870. PubMed ID: 24205004
[TBL] [Abstract][Full Text] [Related]
78. Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.
Nasim FU; Ejaz S; Ashraf M; Asif AR; Oellerich M; Ahmad G; Malik GA; Attiq-Ur-Rehman
Biomark Cancer; 2012; 4():19-34. PubMed ID: 24179392
[TBL] [Abstract][Full Text] [Related]
79. Different Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or Docetaxel.
Taherian A; Mazoochi T
Iran J Basic Med Sci; 2012 Jan; 15(1):669-77. PubMed ID: 23493035
[TBL] [Abstract][Full Text] [Related]
80. Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.
Furrer D; Jacob S; Caron C; Sanschagrin F; Provencher L; Diorio C
Diagn Pathol; 2013 Feb; 8():17. PubMed ID: 23379971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
